Home › Funds › SILVERBACK ASSET MANAGEMENT LLC › LGND
SILVERBACK ASSET MANAGEMENT LLC position in LGND
LIGAND PHARMACEUTICALS INC · Health Care
SILVERBACK ASSET MANAGEMENT LLC reported holding 25,000,000 shares of LGND (LIGAND PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$42.0M, representing 3.69% of its reported portfolio and ranking #7 among its reported holdings. SILVERBACK ASSET MANAGEMENT LLC first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How SILVERBACK ASSET MANAGEMENT LLC's LGND position evolved
SILVERBACK ASSET MANAGEMENT LLC first disclosed a stake in LGND in Q3 2026 at 25,000,000 shares (US$42.0M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 25.00M | $42.00M | New |
About LGND and 13F data
LGND (LIGAND PHARMACEUTICALS INC) is a Health Care company. 48 other funds we track also report a position in LGND — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$205.7M), Chicago Capital, LLC (US$172.2M), Stephens Investment Management Group LLC (US$139.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LGND
- CONGRESS ASSET MANAGEMENT CO 658.56K sh · $205.71M · Q3 2026
- Chicago Capital, LLC 551.23K sh · $172.19M · Q3 2026
- Stephens Investment Management Group LLC 446.14K sh · $139.36M · Q3 2026
- WOLVERINE ASSET MANAGEMENT LLC 50.37M sh · $84.80M · Q3 2026
- GW&K Investment Management, LLC 241.76K sh · $75.52M · Q3 2026
- RICE HALL JAMES & ASSOCIATES, LLC 223.91K sh · $69.94M · Q3 2026
- NEXT CENTURY GROWTH INVESTORS LLC 192.39K sh · $60.10M · Q3 2026
- Ranger Investment Management, L.P. 185.65K sh · $57.99M · Q3 2026
- Private Capital Management, LLC 166.02K sh · $52.48M · Q2 2026
- ASHFORD CAPITAL MANAGEMENT INC 166.34K sh · $51.96M · Q3 2026
- Granahan Investment Management, LLC 154.32K sh · $48.20M · Q3 2026
More on SILVERBACK ASSET MANAGEMENT LLC
FAQ
How long has SILVERBACK ASSET MANAGEMENT LLC held LGND?
SILVERBACK ASSET MANAGEMENT LLC has disclosed LGND holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is SILVERBACK ASSET MANAGEMENT LLC's current position in LGND?
As of Q3 2026, SILVERBACK ASSET MANAGEMENT LLC holds 25.00M shares of LGND (LIGAND PHARMACEUTICALS INC), valued at $42.00M, representing 3.69% of its reported portfolio and ranking #7.
Has SILVERBACK ASSET MANAGEMENT LLC been buying or selling LGND?
In the latest 13F filing (Q3 2026), SILVERBACK ASSET MANAGEMENT LLC newly opened its position in LGND.
Which other funds hold LGND?
Other major institutional holders of LGND include CONGRESS ASSET MANAGEMENT CO, Chicago Capital, LLC, Stephens Investment Management Group LLC, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.